Connection

Prabhakar Baliga to Kidney Transplantation

This is a "connection" page, showing publications Prabhakar Baliga has written about Kidney Transplantation.
Connection Strength

12.640
  1. Early Assessment of National Kidney Allocation Policy Change. J Am Coll Surg. 2022 04 01; 234(4):565-570.
    View in: PubMed
    Score: 0.449
  2. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.411
  3. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128.
    View in: PubMed
    Score: 0.338
  4. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
    View in: PubMed
    Score: 0.333
  5. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.327
  6. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592.
    View in: PubMed
    Score: 0.314
  7. Social Media Use Among Living Kidney Donors and Recipients: Survey on Current Practice and Potential. J Med Internet Res. 2016 12 20; 18(12):e328.
    View in: PubMed
    Score: 0.312
  8. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
    View in: PubMed
    Score: 0.310
  9. Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors. Prog Transplant. 2016 Dec; 26(4):292-298.
    View in: PubMed
    Score: 0.305
  10. A patient navigator and education program for increasing potential living donors: a comparative observational study. Clin Transplant. 2016 05; 30(5):619-27.
    View in: PubMed
    Score: 0.296
  11. Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
    View in: PubMed
    Score: 0.288
  12. Health literacy and kidney transplant outcomes. Prog Transplant. 2015 Mar; 25(1):85-90.
    View in: PubMed
    Score: 0.275
  13. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30.
    View in: PubMed
    Score: 0.274
  14. Development and testing of a disease-specific health literacy measure in kidney transplant patients. Prog Transplant. 2014 Sep; 24(3):263-70.
    View in: PubMed
    Score: 0.266
  15. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97.
    View in: PubMed
    Score: 0.253
  16. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.252
  17. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8.
    View in: PubMed
    Score: 0.239
  18. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.238
  19. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.235
  20. Barriers facing patients referred for kidney transplant cause loss to follow-up. Kidney Int. 2012 Nov; 82(9):1018-23.
    View in: PubMed
    Score: 0.230
  21. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12.
    View in: PubMed
    Score: 0.230
  22. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View in: PubMed
    Score: 0.229
  23. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.225
  24. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
    View in: PubMed
    Score: 0.200
  25. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7.
    View in: PubMed
    Score: 0.191
  26. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
    View in: PubMed
    Score: 0.191
  27. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.181
  28. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.178
  29. Racial differences in the living kidney donation experience and implications for education. Prog Transplant. 2007 Sep; 17(3):234-40.
    View in: PubMed
    Score: 0.164
  30. Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50.
    View in: PubMed
    Score: 0.160
  31. Healthcare professionals' perceptions of the barriers to living donor kidney transplantation among African Americans. J Natl Med Assoc. 2006 Jun; 98(6):834-40.
    View in: PubMed
    Score: 0.150
  32. Racial differences in coping with the need for kidney transplantation and willingness to ask for live organ donation. Am J Kidney Dis. 2006 Feb; 47(2):324-31.
    View in: PubMed
    Score: 0.147
  33. Multilevel Intervention to Improve Racial Equity in Access to Kidney Transplant. J Am Coll Surg. 2023 Apr 01; 236(4):721-727.
    View in: PubMed
    Score: 0.120
  34. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res. 2022 09; 277:116-124.
    View in: PubMed
    Score: 0.113
  35. National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors. Clin Transplant. 2022 04; 36(4):e14581.
    View in: PubMed
    Score: 0.111
  36. A Dialysis Center Educational Video Intervention Increases Patient Self-Efficacy and Kidney Transplant Evaluations. Prog Transplant. 2022 03; 32(1):27-34.
    View in: PubMed
    Score: 0.110
  37. Viruses in posttransplant thrombotic microangiopathy. Transplantation. 2001 Aug 27; 72(4):750.
    View in: PubMed
    Score: 0.108
  38. Acceptability of a Mobile-Health Living Kidney Donor Advocacy Program for Black Wait-Listed Patients. Int J Environ Res Public Health. 2021 08 04; 18(16).
    View in: PubMed
    Score: 0.107
  39. The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
    View in: PubMed
    Score: 0.106
  40. Cadaveric renal transplantation in African-Americans in South Carolina. Clin Transpl. 2001; 143-7.
    View in: PubMed
    Score: 0.103
  41. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
    View in: PubMed
    Score: 0.101
  42. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation. Am J Transplant. 2021 03; 21(3):1197-1205.
    View in: PubMed
    Score: 0.101
  43. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.097
  44. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.094
  45. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.092
  46. The non-directed living kidney donor: Why donate to strangers? J Ren Care. 2019 Jun; 45(2):102-110.
    View in: PubMed
    Score: 0.091
  47. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2019 01; 19(1):98-109.
    View in: PubMed
    Score: 0.088
  48. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.083
  49. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.080
  50. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699.
    View in: PubMed
    Score: 0.080
  51. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
    View in: PubMed
    Score: 0.079
  52. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. Transplantation. 2017 Jan; 101(1):157-165.
    View in: PubMed
    Score: 0.078
  53. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139.
    View in: PubMed
    Score: 0.078
  54. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
    View in: PubMed
    Score: 0.078
  55. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.
    View in: PubMed
    Score: 0.076
  56. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.
    View in: PubMed
    Score: 0.076
  57. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
    View in: PubMed
    Score: 0.075
  58. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
    View in: PubMed
    Score: 0.075
  59. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.075
  60. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
    View in: PubMed
    Score: 0.074
  61. Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
    View in: PubMed
    Score: 0.072
  62. Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23.
    View in: PubMed
    Score: 0.071
  63. African American kidney transplant patients' perspectives on challenges in the living donation process. Prog Transplant. 2015 Jun; 25(2):164-75.
    View in: PubMed
    Score: 0.070
  64. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
    View in: PubMed
    Score: 0.070
  65. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
    View in: PubMed
    Score: 0.070
  66. Living Donor Kidney Transplantation: Overcoming Disparities in Live Kidney Donation in the US--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1687-95.
    View in: PubMed
    Score: 0.069
  67. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant. 2015 Apr; 15(4):914-22.
    View in: PubMed
    Score: 0.068
  68. Variations in coping stages for individuals with chronic kidney disease: Results from an exploratory study with patient navigators. J Health Psychol. 2016 07; 21(7):1299-310.
    View in: PubMed
    Score: 0.067
  69. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.066
  70. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
    View in: PubMed
    Score: 0.066
  71. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.065
  72. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
    View in: PubMed
    Score: 0.065
  73. Development and validation of a questionnaire to assess fear of kidney failure following living donation. Transpl Int. 2014 Jun; 27(6):570-5.
    View in: PubMed
    Score: 0.065
  74. Association between patient satisfaction and outcomes in kidney transplant. Am J Med Qual. 2015 Mar-Apr; 30(2):180-5.
    View in: PubMed
    Score: 0.064
  75. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.062
  76. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.060
  77. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res. 2013 Jan 08; 15(1):e6.
    View in: PubMed
    Score: 0.059
  78. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44.
    View in: PubMed
    Score: 0.059
  79. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.059
  80. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4399-406.
    View in: PubMed
    Score: 0.058
  81. Analyses of renal outcome following transplantation adjusting for informative right censoring and demographic factors: A longitudinal study. Ren Fail. 2010 Jul; 32(6):691-8.
    View in: PubMed
    Score: 0.050
  82. No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech. 2009 Apr; 19(2):153-6.
    View in: PubMed
    Score: 0.046
  83. Parenchymal transection of the kidney inflicted by endocatch bag entrapment during a laparoscopic donor nephrectomy. Am J Transplant. 2006 Jan; 6(1):232-5.
    View in: PubMed
    Score: 0.036
  84. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22.
    View in: PubMed
    Score: 0.033
  85. Living donor transplantation of a pelvic kidney. Clin Transplant. 2004 Jun; 18(3):336-8.
    View in: PubMed
    Score: 0.033
  86. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1058-60.
    View in: PubMed
    Score: 0.032
  87. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
    View in: PubMed
    Score: 0.032
  88. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant. 2003 Nov; 18(11):2436-8.
    View in: PubMed
    Score: 0.031
  89. Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. Am J Transplant. 2003 Oct; 3(10):1278-88.
    View in: PubMed
    Score: 0.031
  90. Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery. Clin Transplant. 2001; 15 Suppl 6:59-61.
    View in: PubMed
    Score: 0.026
  91. Laparoscopic donor nephrectomy: impact on an established renal transplant program. Am Surg. 2000 Dec; 66(12):1132-5.
    View in: PubMed
    Score: 0.026
  92. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation. Clin Transplant. 1999 Dec; 13(6):526-30.
    View in: PubMed
    Score: 0.024
  93. Abbreviating area under the curves further: a practical approach to monitoring extended pharmacokinetics with Neoral. Transplant Proc. 1998 Jun; 30(4):1197-8.
    View in: PubMed
    Score: 0.022
  94. Primary enteric drainage of the pancreas revisited: a viable alternative to bladder drainage in simultaneous pancreas-kidney transplants. Transplant Proc. 1998 Mar; 30(2):440.
    View in: PubMed
    Score: 0.021
  95. Effect of race on outcome after kidney and kidney-pancreas transplantation in type 1 diabetic patients. Diabetes Care. 1997 Aug; 20(8):1310-4.
    View in: PubMed
    Score: 0.020
  96. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function. Clin Transplant. 1997 Aug; 11(4):294-8.
    View in: PubMed
    Score: 0.020
  97. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient. Transplant Proc. 1995 Oct; 27(5 Suppl 1):42-3.
    View in: PubMed
    Score: 0.018
  98. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg. 1995 May; 180(5):532-6.
    View in: PubMed
    Score: 0.017
  99. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.
    View in: PubMed
    Score: 0.017
  100. OKT4 epitope correlates with renal allograft survival in African Americans. Cytometry. 1994 Jun 15; 18(2):93-4.
    View in: PubMed
    Score: 0.016
  101. Valve bladder does not affect the outcome of renal transplants in children with renal failure due to posterior urethral valves. Transplant Proc. 1994 Feb; 26(1):115-6.
    View in: PubMed
    Score: 0.016
  102. New patterns of transplant nephrectomy in the cyclosporine era. J Am Coll Surg. 1994 Jan; 178(1):59-64.
    View in: PubMed
    Score: 0.016
  103. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.008
  104. The first 50 pancreas transplants in South Carolina. J S C Med Assoc. 1997 Oct; 93(10):367-72.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.